EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mapping cross‐domain drivers of Alzheimer's disease risk through integrated network analysis

Gregory A Cary, Stephen Keegan, Jesse C Wiley, Jake Gockley, Robert R Butler, Frank M Longo, Allan I Levey, Anna K Greenwood, Karina Leal, Gregory W Carter, Emory‐Sage‐SGC‐JAX TREAT‐AD Center

Alzheimer's & Dementia · 2026-06 · 22 (6)

DOI: 10.1002/alz.71564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 07.06.2026. Verfasst von Gregory A Cary und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Jackson Laboratory, Bar Harbor, Maine, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Protein Interaction Maps. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Alzheimer's disease (AD) is a complex neurodegenerative disorder with numerous known risk factors. Identification of which genetic factors are causal drivers is difficult due to the long disease prodrome in an inaccessible organ. The application of integrative, systems‐level approaches are crucial for addressing this complexity. METHODS Sixteen biological domain specific interaction networks were derived from the top AD risk‐enriched proteins within each domain. Weighted key driver analysis (wKDA) identified influential hub nodes within each network. RESULTS Distinct processes and drivers were identified within each domain's network. Domains including structural stabilization, endolysosome, and lipid metabolism were especially influential. Integrating key drivers across domains identified consistent drivers such as CTNNB1, ACSL1, and ALDH3A2, suggesting fundamental roles contributing to AD risk. DISCUSSION This highly integrative network‐based approach identified context‐dependent drivers and enabled the inference of interactions between domains. The identified drivers suggest potential targets for future therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseProtein Interaction MapsHumansRisk Factors

Stichwörter der Autor:innen

Alzheimer's diseasebiological domainkey drivernetwork

Autor:innen und Institutionen

  • The Jackson Laboratory, Bar Harbor, Maine, USA.
  • Department of Pharmacology and Toxicology, University of Kansas, Lawrence, Kansas, USA.
  • Sage Bionetworks, Seattle, Washington, USA.
  • Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Cary, G. A., Keegan, S., Wiley, J. C., Gockley, J., Butler, R. R., Longo, F. M., Levey, A. I., Greenwood, A. K., Leal, K., Carter, G. W., & Emory‐Sage‐SGC‐JAX TREAT‐AD Center (2026). Mapping cross‐domain drivers of Alzheimer's disease risk through integrated network analysis. Alzheimer's & Dementia, 22(6). https://doi.org/10.1002/alz.71564

Vancouver

Cary GA, Keegan S, Wiley JC, Gockley J, Butler RR, Longo FM, et al. Mapping cross‐domain drivers of Alzheimer's disease risk through integrated network analysis. Alzheimer's & Dementia. 2026;22(6). doi:10.1002/alz.71564

BibTeX
@article{Cary2026,
  author = {Cary, Gregory A and Keegan, Stephen and Wiley, Jesse C and Gockley, Jake and Butler, Robert R and Longo, Frank M and Levey, Allan I and Greenwood, Anna K and Leal, Karina and Carter, Gregory W and Emory‐Sage‐SGC‐JAX TREAT‐AD Center, Emory‐Sage‐SGC‐JAX TREAT‐AD Center},
  title = {Mapping cross‐domain drivers of Alzheimer's disease risk through integrated network analysis},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {6},
  doi = {10.1002/alz.71564}
}
Kostenlos starten →